BACKGROUND: Glutathione S-transferase is often up-regulated in neoplastic tissues. A single previous study found a loss of expression associated with carcinogenesis of the prostate. METHODS: To extend these results, the authors performed immunohistochemical staining for the pi-class of glutathione S-transferase (GSTpi) on 74 archival sequential prostate specimens. The antibody used was derived from rabbits immunized against purified human GSTpi. Paraffin blocks containing both benign tissue and adenocarcinoma were studied. RESULTS: Heterogeneous expression of GSTpi in benign acini was found in 96% of cases, but GSTpi was not expressed in 95% of invasive adenocarcinomas of the prostate, nor was it expressed in any of the foci of high grade prostatic intraepithelial neoplasia. Basal cells of benign acini showed strong, diffuse staining for GSTpi, whereas the secretory luminal epithelium expressed GSTpi weakly and focally. CONCLUSIONS: This study confirms the down-regulation of GSTpi in adenocarcinoma of the prostate and shows that the loss of GSTpi expression is a phenotype associated with malignant transformation.
BACKGROUND: Glutathione S-transferase is often up-regulated in neoplastic tissues. A single previous study found a loss of expression associated with carcinogenesis of the prostate. METHODS: To extend these results, the authors performed immunohistochemical staining for the pi-class of glutathione S-transferase (GSTpi) on 74 archival sequential prostate specimens. The antibody used was derived from rabbits immunized against purified human GSTpi. Paraffin blocks containing both benign tissue and adenocarcinoma were studied. RESULTS: Heterogeneous expression of GSTpi in benign acini was found in 96% of cases, but GSTpi was not expressed in 95% of invasive adenocarcinomas of the prostate, nor was it expressed in any of the foci of high grade prostatic intraepithelial neoplasia. Basal cells of benign acini showed strong, diffuse staining for GSTpi, whereas the secretory luminal epithelium expressed GSTpi weakly and focally. CONCLUSIONS: This study confirms the down-regulation of GSTpi in adenocarcinoma of the prostate and shows that the loss of GSTpi expression is a phenotype associated with malignant transformation.
Authors: Monika Schmelz; Roland Moll; Ulrike Hesse; Anil R Prasad; Jay A Gandolfi; Shirin R Hasan; Marty Bartholdi; Anne E Cress Journal: Eur J Cell Biol Date: 2005-03 Impact factor: 4.492
Authors: X Lin; M Tascilar; W H Lee; W J Vles; B H Lee; R Veeraswamy; K Asgari; D Freije; B van Rees; W R Gage; G S Bova; W B Isaacs; J D Brooks; T L DeWeese; A M De Marzo; W G Nelson Journal: Am J Pathol Date: 2001-11 Impact factor: 4.307
Authors: R Montironi; R Mazzucchelli; R Pomante; D Thompson; V Duval da Silva; L Vaught; P H Bartels Journal: J Clin Pathol Date: 1999-05 Impact factor: 3.411
Authors: B Chaiwun; N Sukhamwang; H Trakultivakorn; B Saha; L Young; D Tsao-Wei; W Y Naritoku; S Groshen; C R Taylor; S A Imam Journal: Br J Cancer Date: 2011-09-06 Impact factor: 7.640
Authors: Delphine Denoyer; Helen B Pearson; Sharnel A S Clatworthy; Zoe M Smith; Paul S Francis; Roxana M Llanos; Irene Volitakis; Wayne A Phillips; Peter M Meggyesy; Shashank Masaldan; Michael A Cater Journal: Oncotarget Date: 2016-06-14